Table of Contents: Preface
Chapter I - Molecular Genetics of Alzheimer’s Disease; pp. 1-23
(Odity Mukherjee; Petra Nowotny; Alison Goate and D.Phil, Washington Univ. School of Medicine, St. Louis, Mo)
Chapter II - Gene Expression Abnormalities Mark the Progression of Alzheimer's Disease; pp. 25-58
(Stephen D. Ginsberg; Shaoli Che; Scott E. Counts and Elliott J. Mufson, Physiology & Neuroscience, N.Y. Univ. School of Medicine, Orangeburg, NY and Dept. of Neurological Sciences, Rush Univ. Medical Center, Chicago, IL)
Chapter III - Presenilins; pp. 59-77
(Gopal Thinakaran, Dept. of Neurobiology and Neurology, Univ. of Chicago, Chicago, IL)
Chapter IV - Taupathy in Alzheimer’s Disease; pp. 79-93
(Roland Brandt and Monika Hundelt Dept. of Neurobiology, Univ. of Osnabrück, Germany)
Chapter V - Intraneuronal -Amyloid-Induced Neurodegeneration and Alzheimer’s Dementia; pp. 95-734
(Sarah L. Cole and Robert Vassar, Northwestern Univ. The Feinberg School of Medicine, Chicago, IL)
Chapter VI - Lipoprotein Receptors in Alzheimer's Disease;
pp. 135-176
(Olav M. Andersen and Thomas E. Willnow, Dept. for Molecular and Cardiovascular Research, Robert-Roessle-Strasse 10, Berlin, Germany)
Chapter VII - Cholesterol and Tau Hyperphosphorylation in Alzheimer’s Disease; pp. 177-191
(Thomas G. Ohm and Volker Meske, Inst. of Integrative Neuroanatomy, Dept. of Clinical Cell- and Neurobiology, Berlin, Germany)
Chapter VIII - Development in Diagnostic and Therapeutic Strategies for Alzheimer’s Disease; pp. 193-250
(Akila Shanmugam, Bernhard Monien and Gal Bitan
Dept. of Neurology, David Geffen School of Medicine, Brain Research Inst. and Molecular Biology Inst., Univ. of Calif., Los Angeles, CA)
Chapter IX - In Vivo Visualization of Amyloid Like Structures with Pet Molecular Imaging Probes; pp. 251-273
(Vladimir Kepe; Sung-Cheng Huang; Nagichettiar Satyamurthy; Gary W. Small and Jorge R. Barrio, David Geffen School of Medicine at UCLA, G.W.S., Univ. of Calif. at Los Angeles, Los Angeles, CA)
Chapter X - Cathepsin-B, Antiamyloidogenesis, and Neuroprotection; pp. 275-302
(Li-Gan, Gladstone Inst. of Neurological Disease, Univ. of Calif. San Francisco, Ca.
Chapter XI - Environmental Enrichment: From Mouse AD Model to AD Therapy; pp. 303-328
(Orly Lazarov and John Larson, Univ. of Illinois at Chicago, Chicago, IL)
Chapter XII - Fragile X Mental Retardation Gene and Dementia;
pp. 329-338
(Maija Castrén1 and Seppo Kaakkola)
Chapter XIII - Category Learning in Parkinson's Disease; pp. 339-365 (J. Vincent Filoteo)
Chapter XIV - Cerebrovascular Disease and Dementia; pp. 367-380
(Ola A. Selnes, Johns Hopkins Univ. School of Medicine, Baltimore, MD)
Chapter XV - Dementia and Hypertension; pp. 381-413
(Jan A. Staessen; Tom Richart; Lutgarde Thijs and Willem H. Birkenhäger, Campus Gasthuisberg, Leuven, Belguim)
Index |